Research collaborators

Nurturing strategic collaborations with researchers aligned with our own research priorities is critical for our success.

By combining our specialist skills with clinical practitioners or by accessing high-cost, cutting-edge infrastructure and expertise outside our field, we can multiply our impact.

We participate in many collaborations that gain competitive grant funding and deliver important results.

Here’s a list of our projects for 2019-2020, including who we’re working with.

Donor Research
Donor Behaviour    
DB15-04 Emotional psychology of blood donors Amanda Thijsen, A/Prof Davison, Prof Barbara Masser, Dr Lisa Anne Williams, Dr Anne van Dongen, Dr Nancy Briggs (University of NSW); Prof Eamonn Ferguson (University of Nottingham) 
DB17-02  Evaluation of tailored interventions to encourage return of deferred donors  Carley Gemelli, A/Prof Tanya Davison, Amanda Thijsen, Sarah Kruse 
DB17-03  Intervening to promote high frequency donation among existing plasma donors  Dr Rachel Thorpe, Lilly Nguyen, Prof Barbara Masser, A/Prof Tanya Davison, Dr Nicola Guerin, Dr Jonas Fooken (Centre for Business and Economics of Health, The University of Queensland) 
DB17-05  Why do plasmapheresis donor lapse? Developing an understanding of what predicts lapse in plasma donors and testing tailored reactivation strategies  Dr Rachel Thorpe, Amanda Thijsen, Prof Barbara Masser, A/Prof Tanya Davison. Lilly Nguyen, Dr Surendra Karki 
DB18-01  Donors aged 50+: Determining how to grow the contribution of mid-late life blood donors   Dr Rachel Thorpe, Prof Barbara Masser and A/Prof Tanya Davison, Mindy Goldman (Donor and Clinical Services, Canadian Blood Services) 
DB18-02  Communications and research with donors: Preferences and implications  Sarah Kruse, Lilly Nguyen, A/Prof Tanya Davison; Dr Rachel Thorpe 
DB19-01  Inroads - The investigation of facilitators and barriers to the retention of ethnically diverse donors in Australia.  Dr Luke Gahan, Prof Barbara Masser, A/Prof Tanya Davison, Dr Rachel Thorpe, Cecilia Mwangi 
Donor Health and Wellbeing    
DH16-01  Iron Stores, Blood Donation, and Long-term Health Outcomes  Dr Surendra Karki, A/Prof Tanya Davison, Prof David O Irving, Prof John Olynyk (Edith Cowan University); A/Prof Katy Bell, Prof Anne Cust (University of Sydney); A/Prof Bette Liu (University of New South Wales); Prof Andrew Hayen (University of Technology, Sydney) 
DH16-02  Frequent Apheresis Donation and Long-term Health Outcomes in Older NSW Blood Donors  Dr Surendra Karki, A/Prof Tanya Davison, Prof David O Irving, Prof John Olynyk (Edith Cowan University); A/Prof Katy Bell, Prof Anne Cust (University of Sydney); A/Prof Bette Liu (University of New South Wales); Prof Andrew Hayen (University of Technology, Sydney) 
DH17-03  Adverse events in blood donors: Understanding and improving donor return behaviour  Amanda Thijsen, A/Prof Barbara Masser, Dr Tanya Davison 
DH19-01  Australian Blood Donor Study - Establishing a Longitudinal Cohort of Blood and Plasma Donors (Pilot study and Phase 1)   Dr Surendra Karki, Prof Barbara Masser, A/Prof Tanya Davison, A/Prof Denese Marks, Dr Rachel Thorpe, Carley Gemelli, Prof David O Irving, Prof Andrew Hayen (University of Technology, Sydney); A/Prof Bette Liu (University of New South Wales), Dr Katja van den Hurk, (Sanquin, The Netherlands), A/Prof Katy Bell (University of Sydney). 
DH19-02  Donation, health and me: Donors’ perspectives of the impact of blood and plasma donation on their health  Dr Nicky Guerin, A/Prof Tanya Davison, Dr Rachel Thorpe, Prof Barbara Masser, Prof Iain Gosbell, Dr Joanna Speedy 
DH19-03  Interventions to improve donor return following a vasovagal reaction  Amanda Thijsen, A/Prof Tanya Davison, Prof Barbara Masser, Lilly Nguyen, Dr Philippe Gilchrist (Macquarie University) 
DH19-04  Analysis of donor return pattern by age at first recruitment in Australia  Dr Surendra Karki, A/Prof Tanya Davison, David Stephen, Peter McDonald 
DH19-05  Improving donor experiences by assessing and responding to individual donor fears  Prof Barbara Masser, A/Prof Tanya Davison, Amanda Thijsen, Dr Philippe Gilchrist (Macquarie University) 
DH19-06  Evaluating the impact increasing a donors Blood Pressure Cuff PrEssure (mmHg) during Phlebotomy has on donation outcomes - the Bicep study  Dr Barbara Bell, Justine O’Donovan, Elizabeth Knight, Maureen Bower, Anna Green, Dr Stephen Wright 
DH19-07  “LaID BAck’ – Lying Inexperienced Donors flat during Blood donAtion  A/Prof Tanya Davison, Amanda Thijsen, Justine O’Donovan, Elizabeth Knight, Dr Jo Speedy, Surendra Karki, Carley Gemelli 
Product Development
Conventional Components     
PD14-01  Quality Monitoring Program (QMP)   Dr Kelly Winter, A/Prof Denese Marks 
PD15-01  Extending the shelf-life of FFP and cryoprecipitate  Dr Kelly Winter, A/Prof Denese Marks 
PD16-01  Frequent donation, iron deficiency and the red cell storage lesion: Is there a link?  Dr Joanne Tan, A/Prof Denese Marks, Prof Catherine Hyland, Dr Joanna Speedy, Dr Janet Wong, Dr Helen Faddy, Dr Rebecca Cardigan, Dr Athinoula Meli, Dr Lesley Bruce, Dr Helen New (NHSBT) 
PD17-04  The role of glycans in clearance of platelet microparticles   Dr Dianne van der Wal, A/Prof Denese Marks, Dr Lacey Johnson 
PD18-01  Lipaemic plasma: Is it increasing, what can we do about it and how does it impact blood products?  Dr Kelly Winter, A/Prof Denese Marks, Amanda Thijsen, Dr Dianne Van Der Wal 
PD18-03  Implementation of apheresis platelets in PAS: Re-optimisation of the platelet cryopreservation process and ongoing product monitoring  A/Prof Denese Marks, Dr Lacey Johnson, Shereen Tan 
PD18-04   Serum eye drop manufacture and usage in Australia  Dr Joanne Tan, Dr Peter Bentley, Dr Peta Dennington, Roberta Dumbrava (University of Western Australia) 
PD19-01  Whole blood for trauma resuscitation: Development of a new blood product  Dr Joanne Tan, A/Prof Denese Marks  
PD19-02/PD18-98 BI  Comparison of X-ray and gamma irradiation on blood components (EXGAM study)   A/Prof Denese Marks, Dr Lacey Johnson, Dr Joanne Tan, Dr April Davis 
Extended Component Storage     
PD14-05  Cold storage of platelets  Dr Lacey Johnson, A/Prof Denese Marks 
PD14-06  Frozen blood stability testing  Dr Lacey Johnson, A/Prof Denese Marks, Dr Janet Wong 
PD14-07  Improvements to red cell cryopreservation   Dr Kelly Winter, Dr Lacey Johnson, A/Prof Denese Marks 
PD15-03  Use of additive solutions for reconstitution of cryopreserved platelets  Dr Lacey Johnson, A/Prof Denese Marks, Lauren Waters (PhD candidate), Dr Larry Dumont (Blood Systems Inc., Denver, USA); Dr Femke Noorman (Netherlands Military Blood Bank); Dr Juraj Petrik (Scottish Blood Transfusion Service); Dr Darryl Crimmins (New Zealand Blood Service); Representatives from Velico Medical, USA;  Dr Jason Acker (Canadian Blood Services); Dr Robert Ben (University of Ottawa), Dr Matthew Padula (University of Technology, Sydney) 
PD18-02  Characterisation of biological response modifiers (BRMs) in transfusible platelet products  Dr Lacey Johnson, A/Prof Denese Marks, Sarah Green (nee Raynel; PhD candidate), Dr Matthew Padula (University of Technology, Sydney) 
PD19-03  Examination of the impact of refrigeration and cryopreservation of the non-haemostatic functions of stored platelets  Dr Lacey Johnson, A/Prof Denese Marks, Ben Wood (PhD candidate), Dr Matthew Padula (University of Technology, Sydney) 
Novel Products    
PD14-09  Development and characterisation of platelet lysates   A/Prof Denese Marks, (previously Dr Celine Loh), Dr ZuFu Lu (University of Sydney); Simon Cooper (Sydney Eye Hospital); Dr Janet Macpherson and Dr James Favaloro (Royal Prince Alfred Hospital); Dr Marian Sturm and Dr Leon Brownrigg (Royal Perth Hospital) 
PD14-10  Development and characterisation of platelet gels  A/Prof Denese Marks (and previously Dr Celine Loh), Dr Shiva Akbarzadeh, Dr Heather Cleland, Dr Mostafiz Rahman (Monash University/Alfred Hospital) 
PD19-04  Removing HLA antigens from platelets   A/Prof Denese Marks, Dr April Davis, Dr James Daly 
Product Safety
 Transfusion transmitted infections (TTI) and emerging risks     
PS14-04  Exotic mosquito‐borne virus threats to Australia (including WNV, CHIKV, LNV etc.): disease burden and consequences for blood supply safety  Dr Helen Faddy; Dr Clive Seed, Elise Hewlett, Prof Robert LP Flower, Francesca Frentiu (Queensland University of Technology) 
PS15-01  Transfusion Transmitted Infections and Emerging Risks - Chikungunya and/or Zika virus emergence and establishment in Australia.  Dr Helen Faddy, Prof Robert LP Flower, Dr Elvina Viennet, Dr Clive Seed, A/Prof Craig Williams (University of South Australia); Gina Mincham (University of South Australia); Brian Montgomery (Metro South Hospital and Health Service); Cassie Jansen (Queensland Department of Health); Francesca Frentiu (Queensland University of Technology) 
PS17-11  Zika virus: how common is exposure among travelling blood donors?  Prof Robert LP Flower, Dr Veronica Hoad, Dr Clive Seed, Sue Ismay, Dr Lina Rustanti, Dr Eileen Roulis, Dr Helen Faddy 
PS17-12  Development of an early warning system for influenza in Australia as a strategy for maintaining blood donor sufficiency.  Dr Helen Faddy, Dr Elvina Viennet, Prof Robert LP Flower, Dr Nicole White, Jessie Roberts, Sam Hames (QUT); Prof Matt Roughan (University of Adelaide) 
PS18-01  Inactivation of Japanese encephalitis virus following treatment with THERAFLEX pathogen inactivation technologies  A/Prof Denese Marks, Dr Lina Rustanti, Dr Helen Faddy, Prof Roy Hall, Prof Paul Young, Dr Jody Hobson Peters, Dr Agathe Colmant (University of Queensland); Dr Ute Graveman, Prof Axel Seltsam (German Red Cross Blood Service NSTOB); Frank Tolksdorf, Chryslain Sumian, Stefan Reichenberg (Macopharma) 
PS18-02  Utilising pathogen genomics to improve transfusion safety  Prof Robert LP Flower, Dr Eileen Roulis, Dr Lina Rustanti, Ngoc Minh Hien Phan (QUT PhD student and Blood Service Research Scholar), Dr Michael Watson, Dr Veronica Hoad, Dr Vanessa Clifford, Dr Robert Harley, Wayne Dimech (National Serology Reference Laboratory – NRL) 
Reducing the risk of TRALI     
PS14-07  TRALI- Impact of leucodepletion on platelets  Dr John-Paul Tung, Dr Gabriela Simonova, Dr Sara Chiaretti, Dr Rebecca Wellburn, Fergal Temple, Sanne Engkilde Pedersen, Arlanna Esguerra-Lallen, Elise Hewlett, Prof Robert LP Flower, Prof John Fraser, Sara Diab, Kimble Dunster, Margaret Passmore, Dr Nchafatso Obonyo, Dr Jonathon Millar (The Prince Charles Hospital Critical Care Research Group); Prof Adrian Barnett (Queensland University Of Technology), Fahad Alkhureeb (RMIT) 
PS14-08  Investigating antibody and non-antibody mediated TRALI using laboratory models  Dr John-Paul Tung, Dr Melinda Dean, Dr Sara Chiaretti, Gabriela Simonova, Fergal Temple, Prof John Fraser, Dr Monica Ng (The Prince Charles Hospital Critical Care Research Group); Prof Michael Reade (Australian Defence Force, University of Queensland); Prof Adrian Barnett, Anne-Marie Christensen (QUT) 
PS14-09  Investigating levels of BRMs in donors implicated in clinical cases of TRALI  Dr John-Paul Tung, Dr Melinda Dean, Dr Gabriela Simonova, Annette Sultana, Htet Htet Aung (R&D) Dr Shoma Baidya, Kathryn Goodison (Medical Services/Lookback), Rhonda Holdsworth, Gail Pahn, Mark Burton, Greg Jones, Penny Hassell, Katie Havelburg, David Mahon (Transplantation Services), Prof Matthew Cook, Dr Zuopeng Wu (Department of Immunology, Canberra Hospital) 
PS15-03  Modification of the ovine model to make it more robust  Dr John-Paul Tung, Dr Rebecca Wellburn, Dr Sara Chiaretti, Dr Gabriela Simonova, Fergal Temple, Prof John Fraser, Margaret Passmore (The Prince Charles Hospital Critical Care Research Group), Prof Adrian Barnett (Queensland University of Technology) 
PS15-04  Developing laboratory models to help translate findings from the sheep model to the clinical setting  Dr John-Paul Tung, Dr Melinda Dean, Dr Gabriela Simonova, Dr Rebecca Wellburn, Dr Sara Chiaretti, Prof John Fraser, Prof Michael Reade, Margaret Passmore (The Prince Charles Hospital Critical Care Research Group) 
PS15-05  Understanding how white blood cells contribute to TRALI: The role of Extracellular DNA traps  Dr John-Paul Tung, Dr Sara Chiaretti, Dr Melinda Dean, Prof Damien Harkin and Anne-Marie Christensen (QUT) 
Reducing risk associated with transfusion     
PS14-10  Using a sheep model to understand the effects of transfusion in severe trauma (CHORuS)  Dr John-Paul Tung, Dr Gabriela Simonova, Sanne Engkilde Pedersen, Arlanna Esguerra-Lallen, Prof John Fraser, A/Prof Kiran Shekar, Sara Diab, Kimble Dunster, Margaret Passmore, Dr Natasha van Zyl (The Prince Charles Hospital Critical Care Research Group); Dr Elissa Milford (The Prince Charles Hospital Critical Care Research Group, Australian Defence Force, University of Queensland); Prof Michael Reade (Australian Defence Force, University of Queensland); Prof Adrian Barnett (Queensland University of Technology) 
PS14-11  Using a Sheep model to investigate transfusion of patients with septic shock. (RESUS)  Dr John-Paul Tung, Gabriela Simonova, Annette Sultana, Sanne Pedersen, Arlanna Esguerra-Lallen, Prof John Fraser, A/Prof Kiran Shekar, Dr Liam Byrne, Sara Diab, Kimble Dunster, Margaret Passmore, Dr Kavita Bisht, Cameron Anderson, Connie Boon, Dr Nchafatso Obonyo (The Prince Charles Hospital Critical Care Research Group); Prof Adrian Barnett (Queensland University of Technology) 
PS16-02  Red cell storage duration and procoagulant effects: Role of microparticles and smaller particles  Dr John-Paul Tung, Dr Melinda Dean, Dr Lacey Johnson, Prof Robert LP Flower, Dr Gabriela Simonova, Htet Htet Aung, Marie-Anne Balanant, Emily McDonald, Amelie Babinet, Dr Natalie Pecheniuk (Queensland University of Technology), Ross Baker and Quentin Hughes (Murdoch University and the Perth Blood Institute) 
PS16-04  Immune cell memory in transfusion outcomes – role of DNA methylation  Fenny Chong, Dr Melinda Dean, Dr John Paul Tung 
PS17-02  Development of monoclonal antibodies against human neutrophil antigen 3  Dr John-Paul Tung, Dr Melinda Dean, Prof Robert LP Flower, Filip Radenkovic, Dr Martina Jones, A/Prof Stephen Mahler, Prof Ross Barnard (University of Queensland) 
PS14-13  Transfusion associated immunomodulation in a cohort of cardiac patients – translating laboratory findings to a clinical context  Dr Alexis Perros, Dr Melinda Dean, Dr John-Paul Tung, Prof Robert LP Flower, Kelly Rooks, Dr Helen Faddy, Fenny Chong, Prof John Fraser, (The Prince Charles Hospital); Dr Rishendran Naidoo (The Prince Charles Hospital). 
PS16-03  Do inflammasomes play a role in transfusion related immune modulation?  Dr Melinda Dean, Dr John-Paul Tung, Kelly Rooks and Fenny Chong 
PS16-05  Determine the clinical significance of Red Cell Antibodies: Phase 1  Prof Robert LP Flower, Prof Catherine Hyland, Dr Melinda Dean, Dr John-Paul Tung, Tanya Powley, Thu Tran, Ji Yu (PhD Student). 
PS17-07  Characterising Cell Salvaged Blood  Dr John-Paul Tung, Dr Melinda Dean, Prof Robert LP Flower, Fenny Chong, Dr Alexis Perros, Thu Tran, Dr Maheshi Obeysekera, Dr Michelle Roets (Royal Brisbane and Women’s Hospital) 
PS19-02  Do PRBC prepared by different manufacturing processes modulate inflammasome   Dr John Paul Tung, Dr Melinda Dean, Fenny Chong, Kelly Rooks, Prof Jason Acker (Canadian Blood Services); Dr Philip Norris (Blood Systems Research Institute, USA) 
PS19-03  Understanding the role of platelet protein HMGB1 in transfusion-related immunomodulation. Phase I  Dr John Paul Tung, Dr Melinda Dean, Fenny Chong, Alexis Perros 
Optimising transfusion support for neonates at risk of haemolytic disease of the newborn     
PS14-17  Haemolytic disease of the foetus and newborn (HDFN) associated with blood groups (other than RhD): Digital PCR for this “atypical” panel for blood group typing.  Prof Catherine Hyland, Helen O’Brien, Genghis Lopez, Candice Davison, Glenda Millard, Prof Robert LP Flower, Dr James Daly, Tanya Powley and Dr Yew-Wah Liew, Dr Glenn Gardener (Centre for Maternal Fetal Medicine, Mater Health Services); Frances Maguire (Mater Research) 
PS16-06  The efficacy of anti-D prophylaxis in obstetric cohorts with high body mass index  Prof Catherine Hyland, Dr Elizna Schoeman, Glenda Millard, Helen O’Brien, Genghi Lopez, Eunike McGowan, Tanya Powley, Prof Robert LP Flower, Christine Knauth (Queensland University of Technology) 
PS14-20  Clinical utility of genotyping in solving complex red cell serology using genetic sequencing  Prof Catherine Hyland, Dr Eileen Roulis, Glenda Millard, Candice Davison, Helen O’Brien, Genghis Lopez, Dr Yew-Wah Liew, Tanya Powley, Dr James Daly, Prof Robert LP Flower, Christine Knauth (Queensland University of Technology) 
PS17-03  Comparison of blood group antigen profiles for donors from different ethnic backgrounds  Prof Catherine Hyland (Project Lead), Dr Eileen Roulis, Dr Elizna Schoeman, Tanya Powley, Dr Yew-Wah Liew, Glenda Millard, Helen O’Brien, Genghis Lopez, Eunike McGowan, Prof Robert LP Flower, Prof David O Irving, Dr Shivashankar Nagaraj (IHBI – Queensland University of Technology); Dr Matthew Hobbs (Garvan Institute of Medical Research); A/Prof Marcel Dinger (Garvan Institute of Medical Research) 
PS17-08  Improving management of alloimmunisation against blood group antigens  Prof Catherine Hyland, Eunike (Nysa) McGowan, Dr Eileen Roulis, Serena Ekman - PhD Student (Centre for Biopharmaceutical Innovation) , Dr Xuan Bui - Research Fellow (Centre for Biopharmaceutical Innovation), Prof Robert LP Flower, Christine Knauth (Queensland University of Technology); Dr Martina Jones and Prof Stephen Mahler (Centre for Biopharmaceutical Innovation, Australian Institute of Bioengineering and Nanotechnology, University of Queensland) 
PS18-03  Pilot Study: Molecular profiling of allogeneic serum eye drops  Dr Eileen Roulis, Dr Joanne Tan, Dr Lina Rustanti, Prof Robert LP Flower, A/Prof Denese Marks, Dr Helen Faddy 
PS18-04  Integrated bioinformatics solution to improve the acquisition, management, analysis, and dissemination of next-generation sequence (NGS) data and knowledge within ARCBS.  Prof Catherine Hyland, Dr Eileen Roulis, Candice Davison, Glenda Millard, Prof Robert LP Flower, Dr Shivashankar Nagaraj, Sudhir Jadhao (IHBI – Queensland University of Technology) 
PS19-01  A comprehensive blood group profile for Indigenous Australians: predictions from targeted DNA studies correlated with serology - Phase one  Prof Robert LP Flower, Prof Catherine Hyland, Dr Eileen Roulis, Glenda Millard, Candice Davison, Aoibhe Mulcahy, Tanya Powley, Dr Yew-Wah Liew , Dr James Daly, Maree Perry, Laurie Joyce, A/Prof Maree Toombs, (University of Queensland);Tamika Campbell (Carbal Medical Services, Toowoomba); Dr Shivashankar Nagaraj (Queensland University of Technology) 
Identifying factors leading to the failure of RBC structure and function     
PS15-07  Points of structural failure that lead to failure and storage-related changes  Prof Robert LP Flower, Dr Melinda Dean, Prof YuanTong Gu, Dr Emilie Sauret (Queensland University of Technology); Dr Alex Stilgoe, Prof Halina Rubinsztein-Dunlop, Deborah Santangelo (University of Queensland) 
PS16-08  Novel red blood cell targets for biopharmaceuticals  Prof Robert LP Flower, Prof David O Irving, Fenny Chong, Dr Becky Griffiths, Sandra Sowah, Katelyn Richards, Dr Melinda Dean, Dr Xuan Bui, Prof Steven Mahler and Dr Martina Jones (Centre for Biopharmaceutical Innovation, Australian Institute of Bioengineering and Nanotechnology, University of Queensland) 
Product Usage
Optimising Product Usage     
PU16-03 An alternative to cryoprecipitate  Dr Phillip Mondy, Dr Wayne Dyer, Dr Stephen Wright, Dr James Winearls, Dr Martin Wullschleger, Dr Donald Campbell, Prof John Fraser (Gold Coast University Hospital); Dr Catherine Hurn (Royal Brisbane and Women’s Hospital); Dr Melita Trout (Townsville Hospital) 
PU18-01  Alternatives to red cell transfusion to treat anaemia  Dr Wayne Dyer, Dr John-Paul Tung, Prof David O Irving, Prof John Fraser, A/Prof Gianluigi li Bassi, Dr Jacky Suen, and clinical staff (Critical Care Research Group, Prince Charles Hospital); Prof Marcos Intaglietta, Prof Amy Tsai and A/Prof Perdo Cabrales (Bioengineering, UCSD); Dr Lara Oller, Madrid, Spain; Prof Aryeh Shander (Englewood Hospital and Medical Centre, NJ, USA) 
PU18-05 Validating the optimal dose of normal immunoglobulin for protection against hepatitis A  Dr Helen Faddy, Prof Robert LP Flower, Dr Megan Young (University of Queensland); Prof Allan Cripps (Griffith University); Prof Graeme Nimmo (Pathology Queensland) 
 Clinical trials of novel products     
PU17-01  A pilot randomised, controlled, double-blinded clinical trial of cold-stored platelets vs conventional room temperature stored platelets for the management of bleeding in the ICU.  A/Prof Denese Marks, Dr Lacey Johnson, Prof Michael Reade (University of Queensland) 
PU18-03  CLIP-II: The Cryopreserved vs. Liquid Platelets trial  Dr Lacey Johnson, A/Prof Denese Marks, Prof David O Irving, Prof Michael Reade (University of Queensland) 
Linking usage data with patient outcomes     
PU16-01 Genotype analysis of transfused Australian trauma patients  Dr Rena Hirani, Prof David O Irving, The Garvan Institute of Medical Research provided bioinformatics and interpretation expertise, The Australian Research Genome Facility provided sequencing services and technical expertise 
PU16-02  The incidence of microchimerism in chronically transfused patients  Dr Rena Hirani, Prof David O Irving, Shaba Vakalia, A/Prof David Roxby (Flinders Medical Centre); Dr Chris Ward, Dr Lesley Survela (Royal North Shore Hospital) 
PU16-04  The incidence of microchimerism in paediatric patients  Dr Rena Hirani, Prof David O Irving, Dr Bryony Ross (John Hunter Children’s Hospital) 
PU19-01  What's in the bag?  Dr Rena Hirani, Prof Michael Busch, Dr Mars Stone (Vitalant Research Institute) 
PU19-02  In-depth analysis of patients with transfusion associated microchimerism   Dr Rena Hirani 
Other Initiatives     
PU19-03 Supporting emerging stem cell therapies Dr Melanie Levin, Edmund Neoh, Dr James Daly, Prof David O Irving, Justine O’Donovan, Elizabeth Knight, Shane Winzar, Augustin Raj, Sponsor:Exopharm, Level 17/31 Queen St, Melbourne VIC Clinical Research Organisation: Plunkett Consulting Group, Suite 1.03, Level 2 171 Union Rd Surrey Hills VIC 3127 Australia Clinical Research Manager/ Laboratory: O’Brien Institute of Medical Research, 42 Fitzroy St, Fitzroy Victoria 3065 Australia Investigational Sites: Royal Melbourne Hospital
Cross Disciplinary Collaborations
CD19-01(formerly DH 19-08) Cooperative Research Centre (CRC) contribution for Digital Health Prof David O Irving, Dr Stephen Wright, Prof Louise Ryan (University of Technology, Sydney)
Back to top